Pebblebrook's Q1 Numbers Will Tell Us If the Urban Recovery Bet Is Real
Pebblebrook guided 7.5%-9.0% same-property RevPAR growth for Q1 2026 while still carrying a net loss for 2025 of $65.8 million. The April 29 earnings call will reveal whether that optimism is backed by margin improvement or just busier hotels losing money faster.
Pebblebrook's Q1 2026 same-property hotel EBITDA guidance sits at $70M-$74M. That's the number. Not the RevPAR growth range (7.5%-9.0%), which is what management wants you to focus on. The EBITDA range is what tells you whether revenue is actually flowing to the bottom line or getting absorbed by labor and operating costs on the way down.
Full-year 2025: $1.48 billion in revenue, negative $65.8 million net income. The 2026 outlook brackets somewhere between losing another $10.4 million and earning $3.6 million. That's a $14 million swing and the midpoint is roughly breakeven. For a 44-property, 11,000-room portfolio concentrated in urban and resort markets, breakeven after a year and a half of "recovery" tells you something about the cost structure. Adjusted FFO per diluted share was $1.58 for 2025. Stock trades around $12. You're paying roughly 7.6x trailing FFO for a portfolio that hasn't produced positive net income yet. That's either a deep value play or a trap, and the Q1 call is where we start to find out which.
The balance sheet moves are worth decomposing. $450 million unsecured term loan closed in February, maturing 2031. $650 million revolver extended to October 2029. Two hotel sales in Q4 for $116.3 million, $100 million of which went straight to debt reduction. Management is clearly de-risking the capital structure, which is smart... but selling assets to pay down debt while your stock trades at roughly 50% of NAV (Palogic's estimate, and they're not wrong) means you're liquidating at a discount to fund solvency. An owner I worked with once described this exact dynamic: "I'm selling dollars for fifty cents to keep the lights on." He wasn't wrong either.
The San Francisco story is the one analysts keep pointing to. Truist called it "potentially one of the best storylines" in lodging REIT coverage for 2026. Fine. But "best storyline" and "best returns" aren't the same thing. Pebblebrook has heavy exposure to SF, and the easy comps from 2024-2025 will flatter year-over-year numbers. The question is whether the absolute RevPAR levels in those urban markets generate enough contribution after brand costs, labor, and deferred maintenance to justify the capital tied up in these assets. RevPAR growth on a depressed base is math, not recovery.
Thirteen analysts cover this stock. Six say sell. Five say hold. One buy. One strong buy. That distribution tells you the consensus view: the portfolio is real, the assets are good, but the path to consistent positive net income is still unclear. If Q1 EBITDA comes in at the low end of the $70M-$74M range, expect the NAV discount conversation to intensify. If it comes in above $74M, management buys another quarter of credibility. Either way, the number to watch isn't RevPAR. It's flow-through.
Here's what nobody's telling you... if you're a GM at an urban full-service hotel owned by a public REIT, your Q1 flow-through is the number your asset manager is building a story around right now. Every dollar of RevPAR growth that doesn't hit GOP is a problem for the earnings call narrative. Look at your department-level P&Ls this week. If labor cost per occupied room crept up in January and February, get ahead of it before the questions start. Your asset manager already knows the revenue number. What they need from you is the cost story, and they need it to make sense.